Neuburgh Advisers’s Chemed CHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$2.68M Buy
6,426
+2,176
+51% +$888K 0.08% 183
2019
Q2
$1.53M Buy
4,250
+850
+25% +$284K 0.05% 267
2019
Q1
$1.09M Buy
3,400
+306
+10% +$94K 0.04% 286
2018
Q4
$876K Hold
3,094
0.03% 290
2018
Q3
$989K Buy
3,094
+612
+25% +$195K 0.03% 306
2018
Q2
$799K Hold
2,482
0.03% 322
2018
Q1
$677K Hold
2,482
0.02% 345
2017
Q4
$603K Buy
2,482
+102
+4% +$23.2K 0.02% 379
2017
Q3
$481K Buy
2,380
+374
+19% +$73.5K 0.02% 400
2017
Q2
$410K Buy
2,006
+680
+51% +$135K 0.02% 418
2017
Q1
$242K Buy
1,326
+136
+11% +$23.7K 0.01% 467
2016
Q4
$191K Buy
+1,190
New +$175K 0.01% 475

Other funds holding CHE

Neuburgh Advisers's CHE Position: Q3 2019 in Review

Neuburgh Advisers increased its Chemed (CHE) stake by 51% in Q3 2019, buying an estimated $888K and bringing the position to 6,426 shares worth $2.68M. The position accounts for 0.08% of the portfolio, ranked #183.

Neuburgh Advisers first reported a position in CHE in Q4 2016 and has held it in 12 quarters since. 393 funds tracked by Wall St. Rank hold CHE as of Q3 2019.

  • Neuburgh Advisers held 6,426 shares of Chemed worth $2.68M as of Q3 2019.
  • Neuburgh Advisers bought 2,176 Chemed shares in Q3 2019, an estimated $888K.
  • Chemed made up 0.08% of Neuburgh Advisers's portfolio in Q3 2019, its #183 holding.
  • Neuburgh Advisers first reported a position in Chemed in Q4 2016 and has held it in 12 quarters since.
  • 393 funds tracked by Wall St. Rank held Chemed as of Q3 2019.

Based on Neuburgh Advisers's 13F filing for Q3 2019, filed 14 Nov 2019.